MedSci医学资讯：支持ios/android手机下载和手机3G浏览

2013-05-28 MedSci MedSci原创

MedSci医学资讯：提供临床医学各科最新研究动态、循证医学文献、文献剖析、指南共识，病例讨论等，以及有关SCI论文和基金申请相关知识介绍。同时，提供前沿基础医学和转化医学研究进展，为临床医生随时阅读的口袋书和文献资料库。 [特别推荐]MedSci医学资讯应用下载地址：http://www.medsci.cn/m/ipad.asp（支持ios和android 操作系统） &nb

MedSci医学资讯：提供临床医学各科最新研究动态、循证医学文献、文献剖析、指南共识，病例讨论等，以及有关SCI论文和基金申请相关知识介绍。同时，提供前沿基础医学和转化医学研究进展，为临床医生随时阅读的口袋书和文献资料库。

[特别推荐]MedSci医学资讯应用下载地址：https://www.medsci.cn/m/（支持ios和android 操作系统）

APP版本MedSci首页
1.导航：web版、分学科进展、服务、在线服务
2.看点：医学进展、临床研究知识、会议讲座

APP版本MedSci看点
1．Web版：可直接访问网页版www.medsci.cn ；
2．学科进展：您可以根据自己的兴趣选择学科阅读相关学术资讯；
3．服务：网页MedSci网站服务介绍，便于了解和熟悉MedSci用户服务；
4．在线服务：网页版“MedSci 2016年期刊智能查询系统”

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (7)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=6870, encodeId=901268e007, content=谢谢，好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=112.65.244.92, createdTime=Fri Jan 17 11:24:00 CST 2014, time=2014-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6131, encodeId=1a27613158, content=好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6132, encodeId=63516132b0, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5853, encodeId=76d0585328, content=不错的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Tue Jul 02 10:39:00 CST 2013, time=2013-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779884, encodeId=011d1e7988479, content=<a href='/topic/show?id=6afd2498c4' target=_blank style='color:#2F92EE;'>#Android#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2498, encryptionId=6afd2498c4, topicName=Android)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Mon Jul 22 14:22:00 CST 2013, time=2013-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605969, encodeId=a73316059690c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 30 08:22:00 CST 2013, time=2013-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5744, encodeId=41325e442f, content=好！, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhoumin, createdTime=Tue May 28 23:16:00 CST 2013, time=2013-05-28, status=1, ipAttribution=)]
2014-01-17 112.65.244.92

谢谢，好用

110 0
[GetPortalCommentsPageByObjectIdResponse(id=6870, encodeId=901268e007, content=谢谢，好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=112.65.244.92, createdTime=Fri Jan 17 11:24:00 CST 2014, time=2014-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6131, encodeId=1a27613158, content=好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6132, encodeId=63516132b0, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5853, encodeId=76d0585328, content=不错的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Tue Jul 02 10:39:00 CST 2013, time=2013-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779884, encodeId=011d1e7988479, content=<a href='/topic/show?id=6afd2498c4' target=_blank style='color:#2F92EE;'>#Android#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2498, encryptionId=6afd2498c4, topicName=Android)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Mon Jul 22 14:22:00 CST 2013, time=2013-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605969, encodeId=a73316059690c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 30 08:22:00 CST 2013, time=2013-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5744, encodeId=41325e442f, content=好！, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhoumin, createdTime=Tue May 28 23:16:00 CST 2013, time=2013-05-28, status=1, ipAttribution=)]
2013-09-09 sljdhl

好啊

109 0
[GetPortalCommentsPageByObjectIdResponse(id=6870, encodeId=901268e007, content=谢谢，好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=112.65.244.92, createdTime=Fri Jan 17 11:24:00 CST 2014, time=2014-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6131, encodeId=1a27613158, content=好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6132, encodeId=63516132b0, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5853, encodeId=76d0585328, content=不错的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Tue Jul 02 10:39:00 CST 2013, time=2013-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779884, encodeId=011d1e7988479, content=<a href='/topic/show?id=6afd2498c4' target=_blank style='color:#2F92EE;'>#Android#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2498, encryptionId=6afd2498c4, topicName=Android)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Mon Jul 22 14:22:00 CST 2013, time=2013-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605969, encodeId=a73316059690c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 30 08:22:00 CST 2013, time=2013-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5744, encodeId=41325e442f, content=好！, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhoumin, createdTime=Tue May 28 23:16:00 CST 2013, time=2013-05-28, status=1, ipAttribution=)]
2013-09-09 sljdhl

挺好的

108 0
[GetPortalCommentsPageByObjectIdResponse(id=6870, encodeId=901268e007, content=谢谢，好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=112.65.244.92, createdTime=Fri Jan 17 11:24:00 CST 2014, time=2014-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6131, encodeId=1a27613158, content=好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6132, encodeId=63516132b0, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5853, encodeId=76d0585328, content=不错的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Tue Jul 02 10:39:00 CST 2013, time=2013-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779884, encodeId=011d1e7988479, content=<a href='/topic/show?id=6afd2498c4' target=_blank style='color:#2F92EE;'>#Android#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2498, encryptionId=6afd2498c4, topicName=Android)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Mon Jul 22 14:22:00 CST 2013, time=2013-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605969, encodeId=a73316059690c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 30 08:22:00 CST 2013, time=2013-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5744, encodeId=41325e442f, content=好！, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhoumin, createdTime=Tue May 28 23:16:00 CST 2013, time=2013-05-28, status=1, ipAttribution=)]
2013-07-02 vpssa

不错的app

109 0
[GetPortalCommentsPageByObjectIdResponse(id=6870, encodeId=901268e007, content=谢谢，好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=112.65.244.92, createdTime=Fri Jan 17 11:24:00 CST 2014, time=2014-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6131, encodeId=1a27613158, content=好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6132, encodeId=63516132b0, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5853, encodeId=76d0585328, content=不错的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Tue Jul 02 10:39:00 CST 2013, time=2013-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779884, encodeId=011d1e7988479, content=<a href='/topic/show?id=6afd2498c4' target=_blank style='color:#2F92EE;'>#Android#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2498, encryptionId=6afd2498c4, topicName=Android)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Mon Jul 22 14:22:00 CST 2013, time=2013-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605969, encodeId=a73316059690c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 30 08:22:00 CST 2013, time=2013-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5744, encodeId=41325e442f, content=好！, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhoumin, createdTime=Tue May 28 23:16:00 CST 2013, time=2013-05-28, status=1, ipAttribution=)]
2013-07-22 zhangph

#Android#

26 0
[GetPortalCommentsPageByObjectIdResponse(id=6870, encodeId=901268e007, content=谢谢，好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=112.65.244.92, createdTime=Fri Jan 17 11:24:00 CST 2014, time=2014-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6131, encodeId=1a27613158, content=好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6132, encodeId=63516132b0, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5853, encodeId=76d0585328, content=不错的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Tue Jul 02 10:39:00 CST 2013, time=2013-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779884, encodeId=011d1e7988479, content=<a href='/topic/show?id=6afd2498c4' target=_blank style='color:#2F92EE;'>#Android#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2498, encryptionId=6afd2498c4, topicName=Android)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Mon Jul 22 14:22:00 CST 2013, time=2013-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605969, encodeId=a73316059690c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 30 08:22:00 CST 2013, time=2013-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5744, encodeId=41325e442f, content=好！, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhoumin, createdTime=Tue May 28 23:16:00 CST 2013, time=2013-05-28, status=1, ipAttribution=)]
2013-05-30 ms3994565386320060

#Med#

25 0
[GetPortalCommentsPageByObjectIdResponse(id=6870, encodeId=901268e007, content=谢谢，好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=112.65.244.92, createdTime=Fri Jan 17 11:24:00 CST 2014, time=2014-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6131, encodeId=1a27613158, content=好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6132, encodeId=63516132b0, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a5286937, createdName=sljdhl, createdTime=Mon Sep 09 20:21:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5853, encodeId=76d0585328, content=不错的app, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201205/e96b3d935daf4e258fba69d60175f0ab/b6d3ee4a3a414b8eafaf7c5e905937a2.jpg, createdBy=ad4b83208, createdName=vpssa, createdTime=Tue Jul 02 10:39:00 CST 2013, time=2013-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779884, encodeId=011d1e7988479, content=<a href='/topic/show?id=6afd2498c4' target=_blank style='color:#2F92EE;'>#Android#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2498, encryptionId=6afd2498c4, topicName=Android)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Mon Jul 22 14:22:00 CST 2013, time=2013-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605969, encodeId=a73316059690c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 30 08:22:00 CST 2013, time=2013-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5744, encodeId=41325e442f, content=好！, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhoumin, createdTime=Tue May 28 23:16:00 CST 2013, time=2013-05-28, status=1, ipAttribution=)]
2013-05-28 zhoumin

好！

152 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肾内科

MedSci医学资讯：支持ios/android手机下载和手机3G浏览

相关资讯

科室

工具

服务